ArticlebioRxiv : the preprint server for biology2025
Deregulating m6A regulators leads to altered RNA biology in glioma cell lines.
Syeda Maheen Batool, Hanna Lee, Ana K Escobedo, Denalda Gashi, Kesli Faber, Prerna Khanna, Kase D Haas, Tiffaney Hsia, Bob S Carter, Leonora Balaj
Abstract readPreprint
In one paragraphArticle in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Syeda Maheen BatoolDepartment of Neurosurgery, Massachusetts General Hospital, Harvard Medical School Boston, MA, USA.
Hanna LeeDepartment of Neurosurgery, Massachusetts General Hospital, Harvard Medical School Boston, MA, USA.
Ana K EscobedoDepartment of Neurosurgery, Massachusetts General Hospital, Harvard Medical School Boston, MA, USA.
Denalda GashiDepartment of Neurosurgery, Massachusetts General Hospital, Harvard Medical School Boston, MA, USA.ORCID 0009-0004-3751-6075 Kesli FaberDepartment of Neurosurgery, Massachusetts General Hospital, Harvard Medical School Boston, MA, USA.
Prerna KhannaDepartment of Neurosurgery, Massachusetts General Hospital, Harvard Medical School Boston, MA, USA.
Kase D HaasDepartment of Neurosurgery, Massachusetts General Hospital, Harvard Medical School Boston, MA, USA.
Tiffaney HsiaDepartment of Neurosurgery, Massachusetts General Hospital, Harvard Medical School Boston, MA, USA.
Bob S CarterDepartment of Neurosurgery, Massachusetts General Hospital, Harvard Medical School Boston, MA, USA.
Leonora BalajDepartment of Neurosurgery, Massachusetts General Hospital, Harvard Medical School Boston, MA, USA.ORCID 0000-0003-0931-9715 Funding
Imaging and Liquid Biopsy for Glioma Diagnosis and Treatment MonitoringR01CA239078 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI BALAJ, LEONORA, LEE, HAKHO · 2020 to 2024
$3.1MStandardized Molecular Analyses of Glioma EVsR01CA237500 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI CARTER, BOB S, LEE, HAKHO · 2020 to 2024
$3.0MMolecular subtyping of brain tumors using a blood-based multiplexed assayR01CA291826 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI Leonora Balaj, Bob S Carter · 2025 to 2026
$1.3MNCI NIH HHS R01 CA237500NCI NIH HHS R01 CA239078NCI NIH HHS R01 CA291826
6 · The paper itselfAbstract
N6-methyladenosine (m6A) is the most prevalent internal mRNA modification, enriched in the CNS yet poorly characterized in glioma. Using long-read RNA sequencing, we mapped m6A in an
Indexed as
alternative splicingepitranscriptomicsgliomaisoformN6-methyladenosine (m6A)RNAsignaling
Identifiers
PMID40894734
PMCPMC12393272
What OpenQuestion holds
Textmetadata
LicenceCC BY-ND
Read underepoch 390